VYTRUS BIOTECH EO -01 Cash Flow Quality Index
VYTRUS BIOTECH EO -01 cash flow quality index. VYTRUS BIOTECH EO -01 (V5P) has a Cash Flow Quality Index of 1.35x as of December 2025. Operating cash flow of €3.90 Million exceeds net income of €2.90 Million, indicating high earnings quality where cash backs reported profits. See financial flexibility index of VYTRUS BIOTECH EO -01 to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of VYTRUS BIOTECH EO -01 (2021–2025)
Cash flow quality index of VYTRUS BIOTECH EO -01 from 2021 to 2025. Historical Cash Flow Quality Index for VYTRUS BIOTECH EO -01 across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore cash flow to debt ratio of VYTRUS BIOTECH EO -01 to assess how comfortably operating cash covers total debt obligations.
VYTRUS BIOTECH EO -01 Cash Flow Quality Index by Year (2021–2025)
VYTRUS BIOTECH EO -01 cash flow quality index by year from 2021 to 2025. Year-by-year earnings quality comparison for VYTRUS BIOTECH EO -01. For the full cash flow conversion analysis, see cash efficiency ratio of VYTRUS BIOTECH EO -01.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.35x | €3.90 Million | €2.90 Million | ▼ -25.4% |
| 2024 | 1.81x | €1.84 Million | €1.02 Million | ▲ +8.8% |
| 2023 | 1.66x | €904.39K | €544.94K | ▼ -2.1% |
| 2022 | 1.70x | €1.03 Million | €605.26K | ▲ +70.3% |
| 2021 | 1.00x | €447.92K | €450.02K | — |